Literature DB >> 12622412

Chemokines: new, key players in the pathobiology of pancreatic cancer.

Karen E Hedin1.   

Abstract

The chemokines are a family of peptide hormones that regulate cellular adhesion, migration, proliferation, and survival. Accumulating evidence indicates critical regulatory roles for chemokines during the development of hyperplasias and metastatic tumors. Chemokines promote tumor metastasis, growth, survival, and angiogenesis. In addition, by regulating immunity, chemokines critically regulate anti-tumor immune responses and chronic inflammation such as that associated with various neoplasias. Since chemokine receptors are G-protein coupled receptors that are ideal drug targets, these discoveries presage the development of new and potent anti-cancer drugs that target chemokine receptors. Here, I review the chemokine system and chemokine regulation of neoplasias, with a special emphasis on pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12622412     DOI: 10.1385/IJGC:31:1-3:23

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  39 in total

Review 1.  Viral exploitation and subversion of the immune system through chemokine mimicry.

Authors:  P M Murphy
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

Review 2.  The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention.

Authors:  M A Cascieri; M S Springer
Journal:  Curr Opin Chem Biol       Date:  2000-08       Impact factor: 8.822

3.  Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells.

Authors:  M Nesbit; H Schaider; T H Miller; M Herlyn
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

4.  Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer.

Authors:  J Kleeff; T Kusama; D L Rossi; T Ishiwata; H Maruyama; H Friess; M W Büchler; A Zlotnik; M Korc
Journal:  Int J Cancer       Date:  1999-05-17       Impact factor: 7.396

5.  Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells.

Authors:  G Venkatakrishnan; R Salgia; J E Groopman
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

6.  Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.

Authors:  T Koshiba; R Hosotani; Y Miyamoto; J Ida; S Tsuji; S Nakajima; M Kawaguchi; H Kobayashi; R Doi; T Hori; N Fujii; M Imamura
Journal:  Clin Cancer Res       Date:  2000-09       Impact factor: 12.531

Review 7.  Chemokines and their role in tumor growth and metastasis.

Authors:  J M Wang; X Deng; W Gong; S Su
Journal:  J Immunol Methods       Date:  1998-11-01       Impact factor: 2.303

Review 8.  Genetic markers: the key to early diagnosis and improved survival in pancreatic cancer?

Authors:  R Urrutia; E P DiMagno
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

9.  Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma.

Authors:  H E Wiley; E B Gonzalez; W Maki; M T Wu; S T Hwang
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

10.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

Authors:  A B Lowenfels; P Maisonneuve; G Cavallini; R W Ammann; P G Lankisch; J R Andersen; E P Dimagno; A Andrén-Sandberg; L Domellöf
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

View more
  7 in total

Review 1.  Perineural invasion and associated pain in pancreatic cancer.

Authors:  Aditi A Bapat; Galen Hostetter; Daniel D Von Hoff; Haiyong Han
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

2.  Control of chemokine gradients by the retinal pigment epithelium.

Authors:  Guangpu Shi; Arvydas Maminishkis; Tina Banzon; Stephen Jalickee; Rong Li; Jeffrey Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

3.  Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis.

Authors:  Can Cui; Rui Zhang; Feng Gu; Yunfeng Pei; Li Sun; Yueyang Huang; Guoping Niu; Jian Li
Journal:  J Immunol Res       Date:  2022-05-26       Impact factor: 4.493

Review 4.  Targeting angiogenesis in pancreatic cancer: rationale and pitfalls.

Authors:  Chery Whipple; Murray Korc
Journal:  Langenbecks Arch Surg       Date:  2008-01-22       Impact factor: 3.445

5.  Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases.

Authors:  Andrea Formentini; Olga Prokopchuk; Joern Sträter; Joerg Kleeff; Lukasz Filip Grochola; Gerd Leder; Doris Henne-Bruns; Murray Korc; Marko Kornmann
Journal:  Int J Colorectal Dis       Date:  2008-08-31       Impact factor: 2.571

6.  Inflammatory mechanisms contributing to pancreatic cancer development.

Authors:  Buckminster Farrow; Yuko Sugiyama; Andy Chen; Ekong Uffort; William Nealon; B Mark Evers
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

7.  Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence.

Authors:  Stefanie R Bailey; Michelle H Nelson; Kinga Majchrzak; Jacob S Bowers; Megan M Wyatt; Aubrey S Smith; Lillian R Neal; Keisuke Shirai; Carmine Carpenito; Carl H June; Michael J Zilliox; Chrystal M Paulos
Journal:  Nat Commun       Date:  2017-12-06       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.